Total Payments
$14,429
2024 Payments
$302.71
Companies
35
Transactions
522
Medicare Patients
16,170
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$11,511 (79.8%)
Travel$1,527 (10.6%)
Other$1,295 (9.0%)
Education$95.79 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,511 | 510 | 79.8% |
| Travel and Lodging | $1,527 | 4 | 10.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,295 | 4 | 9.0% |
| Education | $95.79 | 4 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $2,536 | 24 | $0 (2020) |
| Boston Scientific Corporation | $1,276 | 35 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,274 | 16 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,255 | 69 | $0 (2024) |
| Amgen Inc. | $1,055 | 66 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,029 | 55 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $777.10 | 34 | $0 (2022) |
| Abbott Laboratories | $661.79 | 9 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $629.90 | 34 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $579.61 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $302.71 | 14 | PFIZER INC. ($89.31) |
| 2023 | $218.86 | 9 | iRhythm Technologies, Inc. ($86.51) |
| 2022 | $1,033 | 50 | AstraZeneca Pharmaceuticals LP ($129.07) |
| 2021 | $2,511 | 100 | Amgen Inc. ($280.88) |
| 2020 | $1,489 | 75 | Amgen Inc. ($239.39) |
| 2019 | $2,234 | 85 | Boston Scientific Corporation ($476.71) |
| 2018 | $2,621 | 83 | SANOFI-AVENTIS U.S. LLC ($757.14) |
| 2017 | $4,019 | 106 | Medtronic Vascular, Inc. ($2,332) |
All Payment Transactions
522 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/27/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/08/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: WATCHMAN_IC | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.38 | General |
| Category: Cardiovascular | ||||||
| 10/29/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/11/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/17/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.94 | General |
| Category: Cardiovascular | ||||||
| 06/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/06/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/16/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Genetic Disease | ||||||
| 03/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.55 | General |
| Category: Cardiovascular | ||||||
| 02/22/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/07/2024 | PFIZER INC. | VYNDAQEL (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2023 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/16/2023 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Genetic Disease | ||||||
| 11/09/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.48 | General |
| Category: Cardiovascular | ||||||
| 10/03/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/18/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardiology | ||||||
| 06/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/10/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/09/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $31.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/26/2022 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 3,670 | 5,240 | $1.3M | $407,948 |
| 2022 | 36 | 3,848 | 5,080 | $1.2M | $377,335 |
| 2021 | 32 | 4,523 | 5,840 | $1.3M | $453,531 |
| 2020 | 30 | 4,129 | 5,391 | $1.2M | $389,059 |
Total Patients
16,170
Total Services
21,551
Medicare Billing
$1.6M
Procedure Codes
134
All Medicare Procedures & Services
134 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 877 | 1,451 | $428,045 | $146,985 | 34.3% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 268 | 272 | $179,792 | $52,417 | 29.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 307 | 317 | $184,669 | $52,047 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 176 | 176 | $77,792 | $22,836 | 29.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 71 | 133 | $36,841 | $13,261 | 36.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 269 | 273 | $41,223 | $12,584 | 30.5% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 19 | 22 | $33,814 | $9,514 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 136 | $27,744 | $9,505 | 34.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 63 | 66 | $35,442 | $9,211 | 26.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 164 | 169 | $33,293 | $8,912 | 26.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 45 | 48 | $37,200 | $8,537 | 22.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 67 | 114 | $22,591 | $7,511 | 33.2% |
| 92941 | Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | Facility | 2023 | 13 | 14 | $24,192 | $7,300 | 30.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 49 | 103 | $19,776 | $6,513 | 32.9% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 13 | 116 | $11,644 | $6,364 | 54.7% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 269 | 273 | $25,935 | $5,994 | 23.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 36 | $14,220 | $5,038 | 35.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 284 | 305 | $14,335 | $3,609 | 25.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 20 | 160 | $10,400 | $3,076 | 29.6% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 13 | 118 | $8,614 | $2,450 | 28.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 61 | 78 | $5,772 | $1,632 | 28.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 53 | 66 | $5,478 | $1,628 | 29.7% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 19 | 173 | $5,536 | $1,547 | 28.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $4,672 | $1,457 | 31.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $4,368 | $1,308 | 29.9% |
About Dr. Sanjay Kumar, M.D
Dr. Sanjay Kumar, M.D is a Interventional Cardiology healthcare provider based in Santa Barbara, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205948288.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sanjay Kumar, M.D has received a total of $14,429 in payments from pharmaceutical and medical device companies, with $302.71 received in 2024. These payments were reported across 522 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($11,511).
As a Medicare-enrolled provider, Kumar has provided services to 16,170 Medicare beneficiaries, totaling 21,551 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 134 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Santa Barbara, CA
- Active Since 08/31/2006
- Last Updated 09/21/2012
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1205948288
Products in Payments
- Resolute (Device) $2,225
- MULTAQ (Drug) $1,127
- ELIQUIS (Drug) $1,058
- XARELTO (Drug) $1,029
- BRILINTA (Drug) $876.08
- LifeVest (Device) $777.10
- Repatha (Biological) $754.16
- ENTRESTO (Drug) $586.82
- WATCHMAN (Device) $371.96
- Vascepa (Drug) $365.30
- Corlanor (Drug) $300.56
- Vascular Closure Devices (Device) $300.00
- Xience V coronary stent system (Device) $289.36
- Livalo (Drug) $266.89
- RESONATE (Device) $263.46
- FARXIGA (Drug) $256.30
- JARDIANCE (Drug) $239.62
- PRADAXA (Drug) $223.12
- NEXLETOL (Drug) $199.97
- ONPATTRO (Drug) $196.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Santa Barbara
Joseph Aragon, M.d, M.D
Interventional Cardiology — Payments: $361,919
Interventional Cardiology $361,919
Michael Shenoda, Md, MD
Interventional Cardiology — Payments: $92,784
Interventional Cardiology $92,784
Bina Ahmed, Md, MD
Interventional Cardiology — Payments: $1,738
Interventional Cardiology $1,738